Published in
Ferrata Storti Foundation, Haematologica, 10(102), p. 1776-1784
DOI: 10.3324/haematol.2017.164632
Links
Tools
The BET bromodomain inhibitor CPI203 improves lenalidomide and dexamethasone activity in in vitro and in vivo models of multiple myeloma by blockade of Ikaros and MYC signaling
Journal article published in 2017 by
Tania Díaz,
Vanina Rodríguez,
Ester Lozano,
Mari-Pau Mena,
Marcos Calderón,
Laura Rosiñol,
Antonio Martínez 
,
Natalia Tovar,
Patricia Pérez-Galán,
Joan Bladé,
Gaël Roué,
Carlos Fernández de Larrea
,
Natalia Tovar,
Patricia Pérez-Galán,
Joan Bladé,
Gaël Roué,
Carlos Fernández de Larrea
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Postprint:
archiving forbidden
Data provided by 